{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:28:19Z","timestamp":1771486099748,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T00:00:00Z","timestamp":1720915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T00:00:00Z","timestamp":1720915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To develop and validate a model for predicting suboptimal debulking surgery (SDS) of serous ovarian carcinoma (SOC) using radiomics method, clinical and MRI features.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>228 patients eligible from institution A (randomly divided into the training and internal validation cohorts) and 45 patients from institution B (external validation cohort) were collected and retrospectively analyzed. All patients underwent abdominal pelvic enhanced MRI scan, including T2-weighted imaging fat-suppressed fast spin-echo (T2FSE), T1-weighted\u00a0dual-echo\u00a0magnetic resonance\u00a0imaging (T1DEI), diffusion weighted imaging (DWI), and T1 with contrast enhancement (T1CE). We extracted, selected and eliminated highly correlated radiomic features for each sequence. Then, Radiomic models were made by each single sequence, dual-sequence (T1CE\u2009+\u2009T2FSE), and all-sequence, respectively. Univariate and multivariate analyses were performed to screen the clinical and MRI independent predictors. The radiomic model with the highest area under the curve (AUC) was used to combine the independent predictors as a combined model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The optimal radiomic model was based on dual sequences (T2FSE\u2009+\u2009T1CE) among the five radiomic models (AUC\u2009=\u20090.720, P\u2009&lt;\u20090.05). Serum carbohydrate antigen 125, the relationship between sigmoid colon\/rectum and ovarian mass or mass implanted in Douglas\u2019 pouch, diaphragm nodules, and peritoneum\/mesentery nodules were considered independent predictors. The AUC of the radiomic\u2013clinical\u2013radiological model was higher than either the optimal radiomic model or the clinical\u2013radiological model in the training cohort (AUC\u2009=\u20090.908 vs. 0.720\/0.854).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The radiomic\u2013clinical\u2013radiological model has an overall algorithm reproducibility and may help create individualized treatment programs and improve the prognosis of patients with SOC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00261-024-04343-3","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T06:01:31Z","timestamp":1720936891000},"page":"496-512","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Radiomics combined with clinical and MRI features may provide preoperative evaluation of suboptimal debulking surgery for serous ovarian carcinoma"],"prefix":"10.1007","volume":"50","author":[{"given":"Li","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenfei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yudong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangfen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianrui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weidao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juncai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,14]]},"reference":[{"key":"4343_CR1","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1245\/s10434-012-2446-8","volume":"19","author":"SJ Chang","year":"2012","unstructured":"Chang SJ, Bristow RE, Ryu HS. Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer. Ann Surg Oncol 2012;19:4059-67.","journal-title":"Ann Surg Oncol"},{"key":"4343_CR2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ygyno.2013.08.005","volume":"131","author":"A Fagotti","year":"2013","unstructured":"Fagotti A, Vizzielli G, Fanfani F, Costantini B, Ferrandina G, Gallotta V, Gueli Alletti S, Tortorella L, Scambia G. Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: impact on prognosis in a single institution experience. Gynecol Oncol 2013;131:341-6.","journal-title":"Gynecol Oncol"},{"key":"4343_CR3","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.6004\/jnccn.2016.0122","volume":"14","author":"RJ Morgan Jr","year":"2016","unstructured":"Morgan RJ Jr, Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Behbakht K, Chen LM, Copeland L, Crispens MA, DeRosa M, Dorigo O, Gershenson DM, Gray HJ, Hakam A, Havrilesky LJ, Johnston C, Lele S, Martin L, Matulonis UA, O'Malley DM, Penson RT, Percac-Lima S, Pineda M, Plaxe SC, Powell MA, Ratner E, Remmenga SW, Rose PG, Sabbatini P, Santoso JT, Werner TL, Burns J, Hughes M. Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2016;14:1134-63.","journal-title":"J Natl Compr Canc Netw"},{"key":"4343_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/464123","volume":"2015","author":"MJ Rutten","year":"2015","unstructured":"Rutten MJ, Sonke GS, Westermann AM, van Driel WJ, Trum JW, Kenter GG, Buist MR. Prognostic Value of Residual Disease after Interval Debulking Surgery for FIGO Stage IIIC and IV Epithelial Ovarian Cancer. Obstet Gynecol Int 2015;2015:464123.","journal-title":"Obstet Gynecol Int"},{"key":"4343_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/01.AOG.0000192407.04428.bb","volume":"107","author":"GD Aletti","year":"2006","unstructured":"Aletti GD, Dowdy SC, Gostout BS, Jones MB, Stanhope CR, Wilson TO, Podratz KC, Cliby WA. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet Gynecol 2006;107:77-85.","journal-title":"Obstet Gynecol"},{"key":"4343_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ygyno.2006.03.051","volume":"103","author":"DS Chi","year":"2006","unstructured":"Chi DS, Eisenhauer EL, Lang J, Huh J, Haddad L, Abu-Rustum NR, Sonoda Y, Levine DA, Hensley M, Barakat RR. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC). Gynecol Oncol 2006;103:559-64.","journal-title":"Gynecol Oncol"},{"key":"4343_CR7","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"A du Bois","year":"2009","unstructured":"du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO). Cancer 2009;115:1234-44.","journal-title":"Cancer"},{"key":"4343_CR8","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ygyno.2016.01.008","volume":"140","author":"JJ Mueller","year":"2016","unstructured":"Mueller JJ, Zhou QC, Iasonos A, O'Cearbhaill RE, Alvi FA, El Haraki A, Eriksson AG, Gardner GJ, Sonoda Y, Levine DA, Aghajanian C, Chi DS, Abu-Rustum NR, Zivanovic O. Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center. Gynecol Oncol 2016;140:436-42.","journal-title":"Gynecol Oncol"},{"key":"4343_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ygyno.2013.01.009","volume":"129","author":"JA Rauh-Hain","year":"2013","unstructured":"Rauh-Hain JA, Nitschmann CC, Worley MJ Jr, Bradford LS, Berkowitz RS, Schorge JO, Campos SM, del Carmen MG, Horowitz NS. Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma. Gynecol Oncol 2013;129:63-8.","journal-title":"Gynecol Oncol"},{"key":"4343_CR10","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1002\/1097-0142(20001001)89:7<1532::AID-CNCR17>3.0.CO;2-A","volume":"89","author":"RE Bristow","year":"2000","unstructured":"Bristow RE, Duska LR, Lambrou NC, Fishman EK, O'Neill MJ, Trimble EL, Montz FJ. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer 2000;89:1532-40.","journal-title":"Cancer"},{"key":"4343_CR11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/cncr.20376","volume":"101","author":"SC Dowdy","year":"2004","unstructured":"Dowdy SC, Mullany SA, Brandt KR, Huppert BJ, Cliby WA. The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma. Cancer 2004;101:346-52.","journal-title":"Cancer"},{"key":"4343_CR12","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/sj.bjc.6605292","volume":"101","author":"G Ferrandina","year":"2009","unstructured":"Ferrandina G, Sallustio G, Fagotti A, Vizzielli G, Paglia A, Cucci E, Margariti A, Aquilani L, Garganese G, Scambia G. Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial. Br J Cancer 2009;101:1066-73.","journal-title":"Br J Cancer"},{"key":"4343_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.611617","volume":"10","author":"Y Gu","year":"2020","unstructured":"Gu Y, Qin M, Jin Y, Zuo J, Li N, Bian C, Zhang Y, Li R, Wu YM, Wang CY, Zhang KQ, Yue Y, Wu LY, Pan LY. A Prediction Model for Optimal Primary Debulking Surgery Based on Preoperative Computed Tomography Scans and Clinical Factors in Patients With Advanced Ovarian Cancer: A Multicenter Retrospective Cohort Study. Front Oncol 2020;10:611617.","journal-title":"Front Oncol"},{"key":"4343_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ejca.2017.06.010","volume":"83","author":"K Michielsen","year":"2017","unstructured":"Michielsen K, Dresen R, Vanslembrouck R, De Keyzer F, Amant F, Mussen E, Leunen K, Berteloot P, Moerman P, Vergote I, Vandecaveye V. Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer. Eur J Cancer 2017;83:88-98.","journal-title":"Eur J Cancer"},{"key":"4343_CR15","volume":"123","author":"S Rizzo","year":"2020","unstructured":"Rizzo S, De Piano F, Buscarino V, Pagan E, Bagnardi V, Zanagnolo V, Colombo N, Maggioni A, Del Grande M, Del Grande F, Bellomi M, Aletti G. Pre-operative evaluation of epithelial ovarian cancer patients: Role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study. Eur J Radiol 2020;123:108786.","journal-title":"A single-centre study. Eur J Radiol"},{"key":"4343_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ygyno.2017.02.020","volume":"145","author":"RS Suidan","year":"2017","unstructured":"Suidan RS, Ramirez PT, Sarasohn DM, Teitcher JB, Iyer RB, Zhou Q, Iasonos A, Denesopolis J, Zivanovic O, Long Roche KC, Sonoda Y, Coleman RL, Abu-Rustum NR, Hricak H, Chi DS. A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer. Gynecol Oncol 2017;145:27-31.","journal-title":"Gynecol Oncol"},{"key":"4343_CR17","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1007\/s00330-013-2837-7","volume":"23","author":"M Espada","year":"2013","unstructured":"Espada M, Garcia-Flores JR, Jimenez M, Alvarez-Moreno E, De Haro M, Gonzalez-Cortijo L, Hernandez-Cortes G, Martinez-Vega V, Sainz De La Cuesta R. Diffusion-weighted magnetic resonance imaging evaluation of intra-abdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinoma. Eur Radiol 2013;23:2636-42.","journal-title":"Eur Radiol"},{"key":"4343_CR18","doi-asserted-by":"publisher","first-page":"7855","DOI":"10.1007\/s00330-021-07902-0","volume":"31","author":"H Li","year":"2021","unstructured":"Li H, Zhang R, Li R, Xia W, Chen X, Zhang J, Cai S, Li Y, Zhao S, Qiang J, Peng W, Gu Y, Gao X. Noninvasive prediction of residual disease for advanced high-grade serous ovarian carcinoma by MRI-based radiomic-clinical nomogram. Eur Radiol 2021;31:7855-64.","journal-title":"Eur Radiol"},{"key":"4343_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5301\/tj.5000396","volume":"102","author":"A Alessi","year":"2016","unstructured":"Alessi A, Martinelli F, Padovano B, Serafini G, Lorusso D, Lorenzoni A, Ditto A, Lecce F, Mira M, Donfrancesco C, Raspagliesi F, Crippa F. FDG-PET\/CT to predict optimal primary cytoreductive surgery in patients with advanced ovarian cancer: preliminary results. Tumori 2016;102:103-7.","journal-title":"Tumori"},{"key":"4343_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ygyno.2014.11.004","volume":"136","author":"SH Shim","year":"2015","unstructured":"Shim SH, Lee SJ, Kim SO, Kim SN, Kim DY, Lee JJ, Kim JH, Kim YM, Kim YT, Nam JH. Nomogram for predicting incomplete cytoreduction in advanced ovarian cancer patients. Gynecol Oncol 2015;136:30-6.","journal-title":"Gynecol Oncol"},{"key":"4343_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/uog.10100","volume":"39","author":"AC Testa","year":"2012","unstructured":"Testa AC, Ludovisi M, Mascilini F, Di Legge A, Malaggese M, Fagotti A, Fanfani F, Salerno MG, Ercoli A, Scambia G, Ferrandina G. Ultrasound evaluation of intra-abdominal sites of disease to predict likelihood of suboptimal cytoreduction in advanced ovarian cancer: a prospective study. Ultrasound Obstet Gynecol 2012;39:99-105.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"4343_CR22","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/COC.0000000000000413","volume":"41","author":"V Andikyan","year":"2018","unstructured":"Andikyan V, Kim A, Gretz HF 3rd, Zakashansky K, Prasad-Hayes M, Beddoe AM, Dottino P, Mandeli J, Chuang L. Laparoscopic Assessment to Determine the Likelihood of Achieving Optimal Cytoreduction in Patients Undergoing Primary Debulking Surgery for Ovarian, Fallopian Tube, or Primary Peritoneal Cancer. Am J Clin Oncol 2018;41:938-42.","journal-title":"Am J Clin Oncol"},{"key":"4343_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.ygyno.2005.09.060","volume":"100","author":"R Angioli","year":"2006","unstructured":"Angioli R, Palaia I, Zullo MA, Muzii L, Manci N, Calcagno M, Panici PB. Diagnostic open laparoscopy in the management of advanced ovarian cancer. Gynecol Oncol 2006;100:455-61.","journal-title":"Gynecol Oncol"},{"key":"4343_CR24","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.ygyno.2004.11.031","volume":"96","author":"A Fagotti","year":"2005","unstructured":"Fagotti A, Fanfani F, Ludovisi M, Lo Voi R, Bifulco G, Testa AC, Scambia G. Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study. Gynecol Oncol 2005;96:729-35.","journal-title":"Gynecol Oncol"},{"key":"4343_CR25","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/j.1600-0412.2011.01227.x","volume":"90","author":"A Fagotti","year":"2011","unstructured":"Fagotti A, Vizzielli G, Costantini B, Lecca A, Gallotta V, Gagliardi ML, Scambia G, Fanfani F. Learning curve and pitfalls of a laparoscopic score to describe peritoneal carcinosis in advanced ovarian cancer. Acta Obstet Gynecol Scand 2011;90:1126-31.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"4343_CR26","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1200\/JCO.2016.69.2962","volume":"35","author":"MJ Rutten","year":"2017","unstructured":"Rutten MJ, van Meurs HS, van de Vrie R, Gaarenstroom KN, Naaktgeboren CA, van Gorp T, Ter Brugge HG, Hofhuis W, Schreuder HW, Arts HJ, Zusterzeel PL, Pijnenborg JM, van Haaften M, Fons G, Engelen MJ, Boss EA, Vos MC, Gerestein KG, Schutter EM, Opmeer BC, Spijkerboer AM, Bossuyt PM, Mol BW, Kenter GG, Buist MR. Laparoscopy to Predict the Result of Primary Cytoreductive Surgery in Patients With Advanced Ovarian Cancer: A Randomized Controlled Trial. J Clin Oncol 2017;35:613-21.","journal-title":"J Clin Oncol"},{"key":"4343_CR27","volume":"3","author":"R van de Vrie","year":"2019","unstructured":"van de Vrie R, Rutten MJ, Asseler JD, Leeflang MM, Kenter GG, Mol B, Buist M. Laparoscopy for diagnosing resectability of disease in women with advanced ovarian cancer. Cochrane Database Syst Rev 2019;3:CD009786.","journal-title":"Cochrane Database Syst Rev"},{"key":"4343_CR28","first-page":"679","volume":"34","author":"CL Fag\u00f6-Olsen","year":"2014","unstructured":"Fag\u00f6-Olsen CL, Ottesen B, Christensen IJ, H\u00f8gdall E, Lundvall L, Nedergaard L, Engelholm SA, Antonsen SL, Lydolph M, H\u00f8gdall C. Biomarkers for predicting complete debulking in ovarian cancer: lessons to be learned. Anticancer Res 2014;34:679-82.","journal-title":"Anticancer Res"},{"key":"4343_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/jbiol128","volume":"8","author":"F Bertucci","year":"2009","unstructured":"Bertucci F, Birnbaum D. Distant metastasis: not out of reach any more. J Biol 2009;8:28.","journal-title":"J Biol"},{"key":"4343_CR30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/annonc\/mdz001","volume":"30","author":"D Dong","year":"2019","unstructured":"Dong D, Tang L, Li ZY, Fang MJ, Gao JB, Shan XH, Ying XJ, Sun YS, Fu J, Wang XX, Li LM, Li ZH, Zhang DF, Zhang Y, Li ZM, Shan F, Bu ZD, Tian J, Ji JF. Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer. Ann Oncol 2019;30:431-8.","journal-title":"Ann Oncol"},{"key":"4343_CR31","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41586-019-0891-2","volume":"566","author":"HA Messal","year":"2019","unstructured":"Messal HA, Alt S, Ferreira R, Gribben C, Wang VM, Cotoi CG, Salbreux G, Behrens A. Tissue curvature and apicobasal mechanical tension imbalance instruct cancer morphogenesis. Nature 2019;566:126-30.","journal-title":"Nature"},{"key":"4343_CR32","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.mri.2022.07.001","volume":"92","author":"J Zhao","year":"2022","unstructured":"Zhao J, Chen W, Liu C, Gao Y, Chen X, Chen G, Xia L, Dai Y, Zhang X. Automatic macaque brain segmentation based on 7T MRI. Magn Reson Imaging 2022;92:232-42.","journal-title":"Magn Reson Imaging"},{"key":"4343_CR33","unstructured":"Zhao W, Chen W, Li G, Lei D, Yang J, Chen Y, Jiang Y, Wu J, Ni B, Sun Y, Wang S, Sun Y, Li M, Liu J. GMILT: A Novel Transformer Network That Can Noninvasively Predict EGFR Mutation Status. IEEE Trans Neural Netw Learn Syst 2022."},{"key":"4343_CR34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00330-020-07091-2","volume":"31","author":"J Jian","year":"2021","unstructured":"Jian J, Li Y, Pickhardt PJ, Xia W, He Z, Zhang R, Zhao S, Zhao X, Cai S, Zhang J, Zhang G, Jiang J, Zhang Y, Wang K, Lin G, Feng F, Wu X, Gao X, Qiang J. MR image-based radiomics to differentiate type \u0399 and type \u0399\u0399 epithelial ovarian cancers. Eur Radiol 2021;31:403-10.","journal-title":"Eur Radiol"},{"key":"4343_CR35","doi-asserted-by":"publisher","first-page":"664","DOI":"10.2214\/AJR.20.23195","volume":"217","author":"HM Li","year":"2021","unstructured":"Li HM, Gong J, Li RM, Xiao ZB, Qiang JW, Peng WJ, Gu YJ. Development of MRI-Based Radiomics Model to Predict the Risk of Recurrence in Patients With Advanced High-Grade Serous Ovarian Carcinoma. AJR Am J Roentgenol 2021;217:664-75.","journal-title":"AJR Am J Roentgenol"},{"key":"4343_CR36","doi-asserted-by":"publisher","first-page":"8730","DOI":"10.1038\/s41598-021-87775-x","volume":"11","author":"S Li","year":"2021","unstructured":"Li S, Liu J, Xiong Y, Pang P, Lei P, Zou H, Zhang M, Fan B, Luo P. A radiomics approach for automated diagnosis of ovarian neoplasm malignancy in computed tomography. Sci Rep 2021;11:8730.","journal-title":"Sci Rep"},{"key":"4343_CR37","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/jmri.27084","volume":"52","author":"Y Li","year":"2020","unstructured":"Li Y, Jian J, Pickhardt PJ, Ma F, Xia W, Li H, Zhang R, Zhao S, Cai S, Zhao X, Zhang J, Zhang G, Jiang J, Zhang Y, Wang K, Lin G, Feng F, Lu J, Deng L, Wu X, Qiang J, Gao X. MRI-Based Machine Learning for Differentiating Borderline From Malignant Epithelial Ovarian Tumors: A Multicenter Study. J Magn Reson Imaging 2020;52:897-904.","journal-title":"J Magn Reson Imaging"},{"key":"4343_CR38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2147\/CMAR.S284220","volume":"13","author":"XP Yu","year":"2021","unstructured":"Yu XP, Wang L, Yu HY, Zou YW, Wang C, Jiao JW, Hong H, Zhang S. MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors. Cancer Manag Res 2021;13:329-36.","journal-title":"Cancer Manag Res"},{"key":"4343_CR39","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.1007\/s00330-019-06124-9","volume":"29","author":"H Zhang","year":"2019","unstructured":"Zhang H, Mao Y, Chen X, Wu G, Liu X, Zhang P, Bai Y, Lu P, Yao W, Wang Y, Yu J, Zhang G. Magnetic resonance imaging radiomics in categorizing ovarian masses and predicting clinical outcome: a preliminary study. Eur Radiol 2019;29:3358-71.","journal-title":"Eur Radiol"},{"key":"4343_CR40","doi-asserted-by":"publisher","first-page":"20210023","DOI":"10.1259\/dmfr.20210023","volume":"50","author":"YM Zheng","year":"2021","unstructured":"Zheng YM, Chen J, Xu Q, Zhao WH, Wang XF, Yuan MG, Liu ZJ, Wu ZJ, Dong C. Development and validation of an MRI-based radiomics nomogram for distinguishing Warthin's tumour from pleomorphic adenomas of the parotid gland. Dentomaxillofac Radiol 2021;50:20210023.","journal-title":"Dentomaxillofac Radiol"},{"key":"4343_CR41","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/mp.12123","volume":"44","author":"M Shafiq-Ul-Hassan","year":"2017","unstructured":"Shafiq-Ul-Hassan M, Zhang GG, Latifi K, Ullah G, Hunt DC, Balagurunathan Y, Abdalah MA, Schabath MB, Goldgof DG, Mackin D, Court LE, Gillies RJ, Moros EG. Intrinsic dependencies of CT radiomic features on voxel size and number of gray levels. Med Phys 2017;44:1050-62.","journal-title":"Med Phys"},{"key":"4343_CR42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1142\/S0219720005001004","volume":"3","author":"C Ding","year":"2005","unstructured":"Ding C, Peng H. Minimum redundancy feature selection from microarray gene expression data. J Bioinform Comput Biol 2005;3:185-205.","journal-title":"J Bioinform Comput Biol"},{"key":"4343_CR43","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1007\/s00330-018-5763-x","volume":"29","author":"X Meng","year":"2019","unstructured":"Meng X, Xia W, Xie P, Zhang R, Li W, Wang M, Xiong F, Liu Y, Fan X, Xie Y, Wan X, Zhu K, Shan H, Wang L, Gao X. Preoperative radiomic signature based on multiparametric magnetic resonance imaging for noninvasive evaluation of biological characteristics in rectal cancer. Eur Radiol 2019;29:3200-9.","journal-title":"Eur Radiol"},{"key":"4343_CR44","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/1745-6215-15-364","volume":"15","author":"JM Wason","year":"2014","unstructured":"Wason JM, Stecher L, Mander AP. Correcting for multiple-testing in multi-arm trials: is it necessary and is it done. Trials 2014;15:364.","journal-title":"Trials"},{"key":"4343_CR45","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.ygyno.2013.05.040","volume":"130","author":"SJ Chang","year":"2013","unstructured":"Chang SJ, Hodeib M, Chang J, Bristow RE. Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis. Gynecol Oncol 2013;130:493-8.","journal-title":"Gynecol Oncol"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04343-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-024-04343-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04343-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T03:02:59Z","timestamp":1736391779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-024-04343-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,14]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["4343"],"URL":"https:\/\/doi.org\/10.1007\/s00261-024-04343-3","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,14]]},"assertion":[{"value":"27 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author (s) declare no conflicts of interest for this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the ethics committee of the First Affiliated Hospital of Chongqing Medical University (NO.: 2022-K474) and individual consent for this retrospective analysis was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}